Announcements Trials
Browse Landscape

Status

Unknown 4Recruiting 4Terminated 3Active not recruiting 3Not yet recruiting 2Completed 2Available 1Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 3Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Pheochromocytoma 2Neuroblastoma 2Insulinoma 2Hypoglycemia 2Hyperinsulinism 2Recurrence 1Paraganglioma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Liposarcoma 1Fibrosarcoma 1Congenital Hyperinsulinism 1Beckwith-Wiedemann Syndrome 1Adenoma, Islet Cell 1

Interventions

3-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Recurrence × Endocrine × Clear all
NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Northwell Health

Available
CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡